Status:
COMPLETED
Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Servier
LivaNova
Conditions:
Heart Failure
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if there is an interest to optimize HF (heart failure) management in patients over 80 years old. The primary objective is to assess the effect of HF (heart fa...
Detailed Description
Aging population, and better management of various heart diseases including ischemic explain the growing up of incidence and prevalence of chronic heart failure. The aging of the population leads now ...
Eligibility Criteria
Inclusion
- Aged over 80 year's old subjects
- Hospitalized for an acute heart failure
- Left Ventricle Ejection Fraction ≤ 35%
- Evaluated life expectancy (Seattle HF score) \> 1 year
Exclusion
- Dementia
- Does not understand French language
- Followed with an optimized management
- With reduced mobility
- Recruited in another clinical trial or in a HF management network
- AHF with curable aetiology : cardiovascular surgery for CABG or valvular replacement, angioplasty
- MDRD \< 30 ml/min/1.73m²
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01437371
Start Date
August 1 2011
End Date
June 1 2014
Last Update
October 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003